Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Medicina
versión On-line ISSN 1561-302X
Resumen
RODRIGUEZ RODRIGUEZ, Nathaliet; ALBIN CANO, Roberto Gabriel y ARCE PUENTES, Dayana. “Di novoˮ heart failure: A diagnostic challenge. Rev. Cuban de Med [online]. 2022, vol.61, n.3 Epub 01-Sep-2022. ISSN 1561-302X.
Introduction:
The term "di novo" heart failure refers to patients without a previous diagnosis of this disease. The review of this issue comes from a real problem, since a group of patients attend secondary care without a previous diagnosis of heart failure and also have in advanced stages.
Objective:
The objective is to provide a clue that facilitates the early diagnosis of heart failure.
Methods:
A bibliographic search was carried out in the following databases: Pubmed, SciELO, ESBCO, Cochrane and BVS, as well as in different medical websites for three months (February 1, 2021 to May 31, 2021).
Conclusions:
The early diagnosis of heart failure will allow us to reduce the number of patients who arrive at Secondary Care without a previous diagnosis. There are classifications that identify early stages of the disease, being in our opinion the ACC / AHA classification the one that should carry the most weight. In primary care this can be a challenge if diagnostic tests such as echocardiography are not used. Dosification of serum levels of type B natriuretic peptide (BNP) and the N-terminal fragment of its protohormone (N-terminal BNP) is very useful. This biomarker should be accessible in outpatient clinics for patients with clinical suspicion of "di novo" heart failure.
Palabras clave : “di novo” heart failure; early diagnosis; echocardiogram; high blood pressure; cardiac biomarkers.